Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.
Saved in:
| Title: | Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T. |
|---|---|
| Authors: | Gustine JN; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Attar N; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Puliafito BR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Cirstea DD; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Branagan AR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Yee AJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Raje NS; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Apr 22; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-026-01510-1 |
